# Collaborative Influenza Vaccine Innovation Centers (CIVICs): Component B: Vaccine Manufacturing and Toxicology Core

> **NIH NIH N01** · DUKE UNIVERSITY · 2024 · $11,116,941

## Abstract

To provide expertise and state-of-the-art approaches to manufacture, formulate, optimize, and evaluate the safety and toxicity of innovative, cutting-edge influenza vaccine platforms and approaches.

## Key facts

- **NIH application ID:** 11057541
- **Project number:** 75N93019C00053-P00024-9999-1
- **Recipient organization:** DUKE UNIVERSITY
- **Principal Investigator:** THOMAS DENNY
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $11,116,941
- **Award type:** —
- **Project period:** 2019-08-26 → 2028-03-13

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11057541

## Citation

> US National Institutes of Health, RePORTER application 11057541, Collaborative Influenza Vaccine Innovation Centers (CIVICs): Component B: Vaccine Manufacturing and Toxicology Core (75N93019C00053-P00024-9999-1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/11057541. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*